Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities - PubMed (original) (raw)
. 1991 Dec 5;266(34):23128-34.
Affiliations
- PMID: 1744111
Free article
Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities
I Clark-Lewis et al. J Biol Chem. 1991.
Free article
Abstract
Interleukin-8 (IL-8) is an inflammatory mediator that stimulates neutrophil migration and functional activation. Analogs of human IL-8 were chemically synthesized, purified, and compared with the full-length 72-residue synthetic IL-8 for their ability to stimulate neutrophil chemotaxis and exocytosis as measured by assaying for release of elastase, as well as their binding to specific receptors in competition assays. Analogs corresponding to the less abundant natural forms, 3-72, 4-72, and 77-residue IL-8, were evaluated and the 3-72 and 4-72 had 2-5-fold higher potencies, whereas the 77-residue IL-8 was 2-fold less potent. A major finding was that NH2-terminal residues 4, 5, and 6 were absolutely essential for IL-8 activity and receptor binding. Quantitative dissociation of elastase release and chemotaxis activity was detected with 5-72, which compared with 1-72, was 80-fold less potent in the elastase assay, but was only slightly less potent in stimulating chemotaxis. IL-8 6-72 lacked all the biological activities tested but had detectable receptor binding activity. The NH2-terminal peptide, AVLPRSAKEL, lacked activity and receptor binding, suggesting that the NH2-terminal region alone is not sufficient for function. Comparison of analogs shortened at the COOH terminus showed that potency was progressively reduced as the COOH-terminal residues were excluded. However activity was retained in an analog (1-51) with the entire COOH-terminal alpha helix and beta turn missing. A peptide corresponding to the COOH-terminal 22 residues, although inactive alone, synergized with the 1-51 analog in stimulating elastase release. The results suggest that the NH2-terminal residues 4, 5, and 6, which are disordered in the IL-8 solution structure, are directly involved in receptor binding, but the COOH-terminal alpha helix is probably important for stabilizing the three-dimensional structure. Other regions within residues 7-51 are also functionally important.
Similar articles
- Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids.
Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M. Clark-Lewis I, et al. J Biol Chem. 1994 Jun 10;269(23):16075-81. J Biol Chem. 1994. PMID: 8206907 - Amino-terminal processing of chemokine ENA-78 regulates biological activity.
Nufer O, Corbett M, Walz A. Nufer O, et al. Biochemistry. 1999 Jan 12;38(2):636-42. doi: 10.1021/bi981294s. Biochemistry. 1999. PMID: 9888803 - Neutrophil activation by monomeric interleukin-8.
Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I. Rajarathnam K, et al. Science. 1994 Apr 1;264(5155):90-2. doi: 10.1126/science.8140420. Science. 1994. PMID: 8140420 - Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
Clark-Lewis I, Moser B, Walz A, Baggiolini M, Scott GJ, Aebersold R. Clark-Lewis I, et al. Biochemistry. 1991 Mar 26;30(12):3128-35. doi: 10.1021/bi00226a021. Biochemistry. 1991. PMID: 2007144 - Structure-activity relationships of chemokines.
Clark-Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B, Moser B, Baggiolini M, Sykes BD. Clark-Lewis I, et al. J Leukoc Biol. 1995 May;57(5):703-11. doi: 10.1002/jlb.57.5.703. J Leukoc Biol. 1995. PMID: 7759949 Review.
Cited by
- Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans.
Pichert A, Schlorke D, Franz S, Arnhold J. Pichert A, et al. Biomatter. 2012 Jul-Sep;2(3):142-8. doi: 10.4161/biom.21316. Biomatter. 2012. PMID: 23507865 Free PMC article. Review. - Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei.
Trevino SR, Klimko CP, Reed MC, Aponte-Cuadrado MJ, Hunter M, Shoe JL, Meyer JR, Dankmeyer JL, Biryukov SS, Quirk AV, Fritts KA, Kern SJ, Fetterer DP, Kohler LJ, Toothman RG, Bozue JA, Schellhase CW, Kreiselmeier N, Daye SP, Welkos SL, Soffler C, Worsham PL, Waag DM, Amemiya K, Cote CK. Trevino SR, et al. PLoS One. 2018 Nov 30;13(11):e0208277. doi: 10.1371/journal.pone.0208277. eCollection 2018. PLoS One. 2018. PMID: 30500862 Free PMC article. - Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M. Forssmann U, et al. J Exp Med. 1997 Jun 16;185(12):2171-6. doi: 10.1084/jem.185.12.2171. J Exp Med. 1997. PMID: 9182688 Free PMC article. - Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.
Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Webb LM, et al. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7158-62. doi: 10.1073/pnas.90.15.7158. Proc Natl Acad Sci U S A. 1993. PMID: 8346230 Free PMC article. - Chemokine receptors and chemokines in HIV infection.
Garzino-Demo A, DeVico AL, Gallo RC. Garzino-Demo A, et al. J Clin Immunol. 1998 Jul;18(4):243-55. doi: 10.1023/A:1027329721892. J Clin Immunol. 1998. PMID: 9710741 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources